| Effects of Coenzyme Q10 (CoQ) in Parkinson Disease (NCT00740714) | Weill Medical College of Cornell University | 2008-12-01 |
| Education in Therapy of Parkinson's Disease (NCT01717144) | University Hospital, Toulouse | 2008-12-01 |
| Long-term Safety and Effectiveness of Levodopa-carbidopa Intestinal Gel Infusion (NCT03602924) | Hospital Universitari Vall d'Hebron Research Institute | 2008-12-01 |
| Clinical Trial on the Effectiveness of Traditional Chinese Medicinal Mixture in Parkinson Disease (NCT00629161) | Fudan University | 2008-11-01 |
| Sensory Stimulation Effect on Movement Speed in Patients With Parkinson Disease (NCT01544738) | Université Libre de Bruxelles | 2008-11-01 |
| Non-interventional Observational Study on WHO-5 Questionnaire Application in Parkinson's Disease (NCT00752388) | Boehringer Ingelheim | 2008-11-01 |
| Prognostic Values of PET Examination With 11 C-Fe_CIT With Voxel-based Analysis Method in Patients With Sporadic Parkonson's Disease and Parkinsonisms (Prot.PD-diagn). (NCT06171451) | IRCCS San Raffaele | 2008-10-12 |
| Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors (NCT00906828) | Uppsala University | 2008-10-01 |
| Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects and in Healthy Male Young Subjects (NCT02092168) | Bial - Portela C S.A. | 2008-10-01 |
| Transcranial Magnetic Stimulation to Treat Parkinson's Disease (NCT00753519) | Mark Hallett | 2008-09-01 |
| Select Stim: Selective Stimulation of the Subthalamic Nucleus in Parkinson's Disease. "A Feasibility Study" (NCT00807703) | Maastricht University Medical Center | 2008-09-01 |
| PET Study of Non-Motor Symptoms of Parkinson Disease (NCT01565473) | University of Michigan | 2008-09-01 |
| Safety Study of Erythropoietin (EPO) in Parkinson's Disease (NCT01010802) | International Center for Neurological Restoration, Cuba | 2008-08-01 |
| P-glycoprotein Function in Brain Diseases (NCT00677885) | National Institute of Mental Health (NIMH) | 2008-05-09 |
| The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease (NCT00762814) | Washington University School of Medicine | 2008-05-01 |
| Pilot Randomized Controlled Trial of Telemedicine for Individuals With Parkinson Disease in a Rural Population (NCT00668551) | University of Rochester | 2008-04-01 |
| State Dependent Resonance in the BG-cortical Loops (NCT00683566) | Assistance Publique Hopitaux De Marseille | 2008-02-01 |
| Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of Life (NCT01100073) | Boehringer Ingelheim | 2008-02-01 |
| Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics (NCT00888186) | Uppsala University | 2008-02-01 |
| Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole (NCT02236728) | Boehringer Ingelheim | 2008-02-01 |
| Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects (NCT00612872) | Institute for Neurodegenerative Disorders | 2008-01-01 |
| Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine (NCT00600093) | Rabin Medical Center | 2008-01-01 |
| Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD). (NCT00601523) | Boehringer Ingelheim | 2008-01-01 |
| Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD (NCT00577460) | Boehringer Ingelheim | 2007-12-01 |
| Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175) (NCT00537017) | Merck Sharp & Dohme LLC | 2007-11-23 |
| Motor Cortex Reward Signaling in Parkinson Disease (NCT00558766) | National Institute of Neurological Disorders and Stroke (NINDS) | 2007-11-08 |
| A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period (NCT00560508) | Boehringer Ingelheim | 2007-11-01 |
| A Single Oral Ascending Dose Study of BIA 9-1067 in Healthy Male Subjects (NCT01520727) | Bial - Portela C S.A. | 2007-10-01 |
| Research of Biomarkers in Parkinson Disease (NCT00465790) | Institut National de la Santé Et de la Recherche Médicale, France | 2007-10-01 |
| Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease (NCT00558025) | Boehringer Ingelheim | 2007-10-01 |
| Augmenting Effects of L-DOPS With Carbidopa and Entacapone (NCT00547911) | National Institute of Neurological Disorders and Stroke (NINDS) | 2007-10-01 |
| Strength Training and Medication Effects in Parkinson Disease Effects on Hypokinesia in Parkinson Disease (NCT00665184) | University of Utah | 2007-08-01 |
| Memory Disorders Registry (NCT00654563) | Cedars-Sinai Medical Center | 2007-08-01 |
| Diagnostic and Prognostic Biomarkers in Parkinson Disease (NCT00653783) | The Parkinson Study Group | 2007-08-01 |
| WiiMote Game Controller as a Device to Study Movement Disorders (NCT00802191) | Vanderbilt University | 2007-08-01 |
| Development of Cognitive Assessment Tools in Parkinson Disease (NCT00556764) | Institute for Neurodegenerative Disorders | 2007-07-01 |
| REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study (NCT00485069) | GlaxoSmithKline | 2007-06-01 |
| Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease (NCT00477802) | University of Cincinnati | 2007-05-01 |
| Characteristics of Parkinson s Disease Associated With the LRRK-2 Gene Mutation (NCT00467090) | National Institute of Neurological Disorders and Stroke (NINDS) | 2007-04-23 |
| Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD) (NCT00434304) | GlaxoSmithKline | 2007-04-09 |
| Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole (NCT00460148) | GlaxoSmithKline | 2007-04-01 |
| Pivotal Study in Advanced Parkinsons Disease Patients (NCT00466167) | Boehringer Ingelheim | 2007-04-01 |
| Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's Disease (NCT00539214) | Boehringer Ingelheim | 2007-03-01 |
| Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease (NCT00480701) | Institute for Neurodegenerative Disorders | 2007-02-01 |
| Assessment of the Biodistribution and Safety of 123-I MZINT in Healthy Subjects and Parkinson Disease Patients (NCT00427674) | Institute for Neurodegenerative Disorders | 2007-01-01 |
| Survey on PD Patients With Depressive Symptoms (NCT00614575) | Boehringer Ingelheim | 2007-01-01 |
| Impact of Switching to Continuous Release Dopamine Agonists (NCT00465452) | University of Toledo | 2007-01-01 |
| Effects of Talampanel on Patients With Advanced Parkinson's Disease (NCT00036296) | Teva Branded Pharmaceutical Products R&D, Inc. | 2006-12-01 |
| Dyskinesia in Parkinson's Disease (Study P04501) (NCT00406029) | Merck Sharp & Dohme LLC | 2006-11-20 |
| A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients (NCT00402233) | Boehringer Ingelheim | 2006-11-01 |
| Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease (NCT00404170) | Institute for Neurodegenerative Disorders | 2006-11-01 |
| A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease (NCT00387075) | Institute for Neurodegenerative Disorders | 2006-11-01 |
| Evaluation of 5-[123I]-A-85380 and SPECT Imaging in Individuals With Parkinsons Disease (NCT00397696) | Institute for Neurodegenerative Disorders | 2006-11-01 |
| ALTROPANE® SPECT Imaging in Patients With Parkinson Disease (NCT00397228) | Molecular NeuroImaging | 2006-11-01 |
| Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With "Wearingoff" Phenomenon (NCT03103399) | Bial - Portela C S.A. | 2006-09-26 |
| Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study) (NCT00617019) | Boehringer Ingelheim | 2006-09-01 |
| Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders. (NCT00355927) | Hadassah Medical Organization | 2006-09-01 |
| A Longitudinal Observational Follow-up of the PRECEPT Study Cohort (NCT00605163) | The Parkinson Study Group | 2006-08-01 |
| DYSCAR: Characterization of Dystonia (NCT00361465) | University Hospital, Grenoble | 2006-08-01 |
| Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg (NCT03097211) | Bial - Portela C S.A. | 2006-07-17 |
| Controlled Trial With Deep Brain Stimulation in Patients With Early Parkinson's Disease (NCT00354133) | German Parkinson Study Group (GPS) | 2006-07-01 |
| A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia (NCT00376506) | National Institute of Neurological Disorders and Stroke (NINDS) | 2006-07-01 |
| A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's (NCT00331149) | GlaxoSmithKline | 2006-06-20 |
| Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations (NCT00302146) | National Human Genome Research Institute (NHGRI) | 2006-05-23 |
| Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD) (NCT00321854) | Boehringer Ingelheim | 2006-05-01 |
| Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics (NCT03094156) | Bial - Portela C S.A. | 2006-04-26 |
| Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1) (NCT00467597) | US Department of Veterans Affairs | 2006-04-01 |
| Profile of Depressive Symptoms in Parkinsons Disease (NCT00349310) | Boehringer Ingelheim | 2006-04-01 |
| Observational Study of Pergolide Mesylate and Cardiac Valvulopathy (NCT00311532) | Eli Lilly and Company | 2006-03-01 |
| Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms (NCT00297778) | Boehringer Ingelheim | 2006-03-01 |
| First Presentation of Parkinson Disease Patients to Neurologist (NCT00802178) | Boehringer Ingelheim | 2006-02-01 |
| Pharmacokinetic Profile of BIA 6-512 in Healthy Elderly Subjects Versus Healthy Young Subjects (NCT03095105) | Bial - Portela C S.A. | 2006-01-24 |
| Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit (NCT00272688) | University Hospital, Akershus | 2006-01-01 |
| Gender Differences in Parkinsonian Patients- a Swedish Register Study (NCT04713306) | Region Jönköping County | 2006-01-01 |
| Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families (NCT00273351) | Institute for Neurodegenerative Disorders | 2006-01-01 |
| Pramipexole Conversion to Ropinirole Controlled Release (CR) (NCT00275275) | Rajesh Pahwa, MD | 2006-01-01 |
| Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease (NCT00552474) | Abbott Medical Devices | 2005-10-01 |
| A Triple-blinded, Randomised, Placebo-controlled Trial to Examine the Efficacy and Safety of ViNeuro in Patients With Parkinson's Disease (NCT00517842) | Hospital Authority, Hong Kong | 2005-10-01 |
| Safety and Efficacy of Motor Cortex Stimulation in the Treatment of Advanced Parkinson Disease (NCT00159172) | Assistance Publique - Hôpitaux de Paris | 2005-09-01 |
| Benefits of Exercise and Education for Individuals With Parkinson's Disease (BEEP) (NCT00167453) | University of Saskatchewan | 2005-09-01 |
| Study of Antidepressants in Parkinson's Disease (NCT00086190) | University of Rochester | 2005-06-01 |
| Effect of Food on BIA 6-512 (Trans-resveratrol) (NCT03095092) | Bial - Portela C S.A. | 2005-05-23 |
| Tolerability and Steady-state Pharmacokinetics of BIA 6-512 (NCT03093389) | Bial - Portela C S.A. | 2005-05-11 |
| Talampanel to Treat Parkinson's Disease (NCT00108667) | National Institute of Neurological Disorders and Stroke (NINDS) | 2005-04-01 |
| Genetic Characterization of Parkinson's Disease (NCT00105131) | National Institute of Neurological Disorders and Stroke (NINDS) | 2005-03-01 |
| Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease (NCT00129181) | Institute for Neurodegenerative Disorders | 2005-01-01 |
| Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients (NCT00144300) | Boehringer Ingelheim | 2005-01-01 |
| Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics (NCT03091868) | Bial - Portela C S.A. | 2004-11-03 |
| Relationship of Dopamine to Cognitive Function in Parkinson's Disease (NCT00094601) | National Institute of Mental Health (NIMH) | 2004-10-18 |
| A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients (NCT00096876) | Institute for Neurodegenerative Disorders | 2004-10-01 |
| Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD) (NCT00641186) | Baylor College of Medicine | 2004-09-01 |
| Lisuride Patch to Treat Parkinson's Disease (NCT00089622) | National Institute of Neurological Disorders and Stroke (NINDS) | 2004-08-04 |
| Biological Markers in Parkinson's Disease (NCT00088335) | National Institute of Neurological Disorders and Stroke (NINDS) | 2004-07-01 |
| Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease (NCT00304161) | University of Pennsylvania | 2004-07-01 |
| Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease. (NCT00174239) | Pfizer | 2004-07-01 |
| Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics (NCT03091543) | Bial - Portela C S.A. | 2004-05-04 |
| Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease (NCT00096720) | Institute for Neurodegenerative Disorders | 2004-02-01 |
| Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa (NCT00613301) | Boehringer Ingelheim | 2004-02-01 |
| Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease (NCT02248181) | Boehringer Ingelheim | 2004-02-01 |
| An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease (NCT00632736) | GlaxoSmithKline | 2004-02-01 |